Doshi Dipal — SEC Form 4 filings
SEC reporting owner CIK 1613084. 13 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-18 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 5 filings — 7,900 shares, $126,190 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 1,600 shares @ $17.81 ($28,497) in Entrada Therapeutics, Inc., filed 2024-07-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | CEO, Director | 11 | — | 7 legs · 7,900 sh · $126,190 | 19 |
| Azenta, Inc. (AZTA) | Director | 2 | — | — | 2 |
Form 4 filings — Doshi Dipal
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Entrada Therapeutics, Inc. (TRDA) | Tax withholding (F): 8,724 @ $7.14 | EDGAR |
| 2026-03-03 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 139,400 @ $0 · Tax withholding (F): 9,869 @ $11.66 · Tax withholding (F): 19,181 @ $11.76 · Grant/award (A): 208,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Azenta, Inc. (AZTA) | Grant/award (A): 5,663 @ $27.85 | EDGAR |
| 2025-09-04 | 4 | Entrada Therapeutics, Inc. (TRDA) | Tax withholding (F): 8,723 @ $5.43 | EDGAR |
| 2025-03-04 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 116,200 @ $0 · Tax withholding (F): 17,566 @ $11.68 · Grant/award (A): 173,400 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Azenta, Inc. (AZTA) | Grant/award (A): 4,040 @ $52.32 | EDGAR |
| 2024-09-05 | 4 | Entrada Therapeutics, Inc. (TRDA) | Tax withholding (F): 2,328 @ $15.76 · Tax withholding (F): 752 @ $16.93 · Tax withholding (F): 72 @ $17.70 · Tax withholding (F): 4,744 @ $15.42 · Tax withholding (F): 826 @ $15.13 | EDGAR |
| 2024-07-16 | 4 | Entrada Therapeutics, Inc. (TRDA) | Sale (S): 300 @ $18 · Sale (S): 1,600 @ $17.81 | EDGAR |
| 2024-06-14 | 4 | Entrada Therapeutics, Inc. (TRDA) | Sale (S): 1,000 @ $16.17 | EDGAR |
| 2024-05-20 | 4 | Entrada Therapeutics, Inc. (TRDA) | Sale (S): 1,800 @ $15 · Sale (S): 1,200 @ $15.11 | EDGAR |
| 2024-03-05 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 104,700 @ $0 · Tax withholding (F): 1,164 @ $12.42 · Tax withholding (F): 1,391 @ $13.37 · Tax withholding (F): 5,049 @ $12.28 · Grant/award (A): 158,500 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | Entrada Therapeutics, Inc. (TRDA) | Sale (S): 1,000 @ $15 | EDGAR |
| 2024-01-18 | 4 | Entrada Therapeutics, Inc. (TRDA) | Sale (S): 1,000 @ $15.99 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1613084 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →